Skip to content

Drug interactions

Indacaterol-glycopyrronium + Posaconazole

Severity: Moderate

Indacaterol-glycopyrronium and Posaconazole: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Posaconazole can prolong the QT interval, and indacaterol may add to this. Posaconazole also inhibits CYP3A4 and P-gp, which may raise indacaterol exposure and increase beta-agonist adverse effects.

What this interaction means in plain words

Indacaterol-glycopyrronium and Posaconazole can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Indacaterol-glycopyrronium belongs to Respiratory; Posaconazole belongs to Anti Fungals.

Evidence level: Moderate

Why it happens

Additive QT prolongation and CYP3A4/P-gp inhibition increasing indacaterol exposure.

What to do

Check ECG and electrolytes at baseline and during therapy, and monitor for tremor, tachycardia and palpitations. Correct hypokalemia promptly.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Indacaterol-glycopyrronium and Posaconazole, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Indacaterol-glycopyrronium with Posaconazole?

MediHelp rates the interaction as moderate. Indacaterol-glycopyrronium and Posaconazole can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Posaconazole can prolong the QT interval, and indacaterol may add to this. Posaconazole also inhibits CYP3A4 and P-gp, which may raise indacaterol exposure and increase beta-agonist adverse effects.

How serious is the interaction between Indacaterol-glycopyrronium and Posaconazole?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Check ECG and electrolytes at baseline and during therapy, and monitor for tremor, tachycardia and palpitations. Correct hypokalemia promptly.

What other medicines interact with Indacaterol-glycopyrronium?

MediHelp also lists interactions of Indacaterol-glycopyrronium with, for example, Amisulpride, Arformoterol, Arsenic trioxide. The full list is on the Indacaterol-glycopyrronium page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in